Deciphera Pharmaceuticals · 1 day ago
Senior Director, Clinical Operations
Deciphera Pharmaceuticals is a company focused on improving the lives of people with cancer. They are seeking a Senior Director of Clinical Operations to lead the clinical operations team, develop clinical program strategies, and ensure the successful execution of clinical trials within established timelines and budgets.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Develop and execute clinical program strategy
Lead and manage the clinical operations team for assigned program(s)
Ensure clinical trials are properly defined, planned, and executed
Assist in authoring key regulatory documents
Ensure study objectives align with clinical development strategy and corporate goals
Manage external vendors to deliver within timelines and budget
Foster a collaborative culture and serve as a leadership role model
Qualification
Required
Bachelor's or Master's degree in health science or related field
12+ years of experience, with a minimum of 10 years in clinical trial management
Expertise in clinical development process, global regulatory requirements, and CRO/vendor management
Excellent leadership, communication, and organizational skills
Benefits
Competitive salary and annual bonus.
Comprehensive benefits package including medical, dental, vision insurance, 401(k) retirement plan with company match, and more.
Generous parental leave and family planning benefits.
Outstanding culture and opportunities for personal and professional growth.
Company
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals focuses on improving kinase inhibitor treatments.
H1B Sponsorship
Deciphera Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2023 (2)
2022 (5)
2021 (5)
2020 (9)
Funding
Current Stage
Public CompanyTotal Funding
$1.01BKey Investors
SV Health InvestorsNew Leaf Venture Partners
2024-04-29Acquired
2023-01-19Post Ipo Equity· $125M
2022-04-27Post Ipo Equity· $172.5M
Leadership Team
Recent News
2025-12-10
2025-11-19
Company data provided by crunchbase